Raul R. Calvo

2.0k citations

22 papers · 1.0k indexed · h-index 16

Co-authors: Fadia E. Ali Tianbao Lu Maxwell D. Cummings Daniel J. Parks Karen L. Milkiewicz Louis V. LaFrance James M. Samanen Jennifer Lattanze
Topics: Platelet Disorders and Treatments (7 papers)Cancer-related Molecular Pathways (6 papers)Cell Adhesion Molecules Research (5 papers)
Cited by: Immunology and Allergy Hematology Oncology
Journals: Journal of the American Chemical Society Advanced Drug Delivery Reviews Journal of Medicinal Chemistry
Partner nations: United States Spain

In The Last Decade

Raul R. Calvo

22 papers receiving 962 citations

Peers

Countries citing papers authored by Raul R. Calvo

Since Specialization

Citations

This map shows the geographic impact of Raul R. Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raul R. Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raul R. Calvo more than expected).

Fields of papers citing papers by Raul R. Calvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raul R. Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raul R. Calvo. The network helps show where Raul R. Calvo may publish in the future.

Co-authorship network of co-authors of Raul R. Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Raul R. Calvo. A scholar is included among the top collaborators of Raul R. Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raul R. Calvo. Raul R. Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep) 2015 ·Journal of Medicinal Chemistry ·William H. Parsons,Raul R. Calvo,Wing S. Cheung,(unknown),Sharmila Patel,Jian Liu,Mark A. Youngman,Scott L. Dax,Dennis J. Stone,Na Qin,Tasha L. Hutchinson,Mary Lou Lubin,Sui‐Po Zhang,Michael Finley,Yi Liu,Michael R. Brandt,Christopher M. Flores,Mark R. Player	19
2	Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Raul R. Calvo,Sanath K. Meegalla,Daniel J. Parks,William H. Parsons,Shelley K. Ballentine,Mary Lou Lubin,Craig R. Schneider,Raymond W. Colburn,Christopher M. Flores,Mark R. Player	31
3	Discovery of piperidine carboxamide TRPV1 antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Wing S. Cheung,Raul R. Calvo,Brett A. Tounge,Sui‐Po Zhang,(unknown),Michael R. Brandt,Tasha L. Hutchinson,Christopher M. Flores,Mark R. Player	15
4	Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Parks,Louis V. LaFrance,Raul R. Calvo,Karen L. Milkiewicz,Juan Marugán,Pierre Raboisson,Carsten J. Schubert,Holly K. Koblish,Shuyuan Zhao,Carol F. Franks,Jennifer Lattanze,Theodore E. Carver,Maxwell D. Cummings,Diane Maguire,Bruce Grasberger,Anna C. Maroney,Tianbao Lu	57
5	Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity 2006 ·Bioorganic & Medicinal Chemistry Letters ·Kristi Leonard,Juan Marugán,Pierre Raboisson,Raul R. Calvo,(unknown),Holly K. Koblish,Jennifer Lattanze,Shuyuan Zhao,Maxwell D. Cummings,Mark R. Player,Anna C. Maroney,Tianbao Lu	49
6	Substituted 1,4‐Benzodiazepine‐2,5‐diones as α‐Helix Mimetic Antagonists of the HDM2‐p53 Protein–Protein Interaction 2006 ·Chemical Biology & Drug Design ·Maxwell D. Cummings,Carsten J. Schubert,Daniel J. Parks,Raul R. Calvo,Louis V. LaFrance,Jennifer Lattanze,Karen L. Milkiewicz,Tianbao Lu	37
7	Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Juan Marugán,Kristi Leonard,Pierre Raboisson,(unknown),Raul R. Calvo,Holly K. Koblish,Jennifer Lattanze,Shuyuan Zhao,Maxwell D. Cummings,Mark R. Player,Carsten J. Schubert,Anna C. Maroney,Tianbao Lu	23
8	Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo 2006 ·Molecular Cancer Therapeutics ·Holly K. Koblish,Shuyuan Zhao,Carol F. Franks,Robert R. Donatelli,(unknown),Louis V. LaFrance,Kristi Leonard,(unknown),Daniel J. Parks,Raul R. Calvo,Karen L. Milkiewicz,Juan Marugán,Pierre Raboisson,Maxwell D. Cummings,Bruce Grasberger,Dana L. Johnson,Tianbao Lu,Christopher J. Molloy,Anna C. Maroney	131
9	1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR 2004 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Parks,Louis V. LaFrance,Raul R. Calvo,Karen L. Milkiewicz,Varsha Gupta,Jennifer Lattanze,(unknown),Theodore E. Carver,Eugene C. Petrella,Maxwell D. Cummings,Diane Maguire,Bruce Grasberger,Tianbao Lu	130
10	Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists 1998 ·Bioorganic & Medicinal Chemistry Letters ·Richard M. Keenan,William H. Miller,M. Amparo Lago,Fadia E. Ali,William E. Bondinell,James F. Callahan,Raul R. Calvo,Russell D. Cousins,Shing‐Mei Hwang,Dalia R. Jakas,Thomas W. Ku,Chet Kwon,Thomas T. Nguyen,(unknown),David J. Rieman,(unknown),Dennis T. Takata,Irene N. Uzinskas,Catherine Yuan,Brian R. Smith	18
11	The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists 1997 ·Advanced Drug Delivery Reviews ·James M. Samanen,Chao‐Pin Lee,Philip L. Smith,William E. Bondinell,Raul R. Calvo,Dalia R. Jakas,Kenneth A. Newlander,Michael F. Parker,Irene N. Uzinskas,Tobias O. Yellin,Andrew J. Nichols	1
12	Interaction between propofol and sulfisoxazole in mice an in vivo and in vitro study. 1996 ·PubMed ·(unknown),Rita Q. Carlos,Miren Zamacona,Roland Jimenez,Raul R. Calvo	1
13	Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist 1995 ·Tetrahedron Letters ·William H. Miller,Thomas W. Ku,Fadia E. Ali,William E. Bondinell,Raul R. Calvo,Larry D. Davis,Karl F. Erhard,(unknown),William F. Huffman,Richard M. Keenan,Chet Kwon,Kenneth A. Newlander,Stephen T. Ross,James M. Samanen,Dennis T. Takata,(unknown)	39
14	The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist 1994 ·Thrombosis Research ·Andrew J. Nichols,(unknown),Richard E. Valocik,(unknown),Barbara L. Storer,Fadia E. Ali,Todd T. Romoff,Raul R. Calvo,James M. Samanen	5
15	Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation 1994 ·Journal of Medicinal Chemistry ·Fadia E. Ali,Donald B. Bennett,Raul R. Calvo,John D. Elliott,Shing‐Mei Hwang,Thomas W. Ku,M. Amparo Lago,Andrew J. Nichols,Todd T. Romoff	35
16	Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide 1993 ·Journal of the American Chemical Society ·Thomas W. Ku,Fadia E. Ali,(unknown),John W. Bean,William E. Bondinell,Joelle L. Burgess,James F. Callahan,Raul R. Calvo,(unknown)	67
17	Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides 1992 ·Journal of Medicinal Chemistry ·Catherine E. Peishoff,Fadia E. Ali,John W. Bean,Raul R. Calvo,(unknown),Drake S. Eggleston,(unknown),Paul F. Koster,Shing Mei Hwang	78
18	Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro 1991 ·Journal of Medicinal Chemistry ·James M. Samanen,(unknown),Todd T. Romoff,Raul R. Calvo,(unknown),(unknown),Barbara L. Storer,D. Berry,D. Bennett,Mark W. Strohsacker,David Powers,Jeffrey M. Stadel,A. Nichols	156
19	Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives 1990 ·Journal of Medicinal Chemistry ·(unknown),John R. Regan,(unknown),Paul R. Menard,Joseph G. Bruno,Raul R. Calvo,(unknown),(unknown),E. S. Neiss,(unknown)	3
20	SK&F 106760, a novel GPIIB/IIIA antagonist: antithrombotic activity and potentiation of streptokinase-mediated thrombolysis 1990 ·European Journal of Pharmacology ·A. Nichols,(unknown),Paul F. Koster,Jean A. Smith,Frank C. Barone,(unknown),Jeffrey M. Stadel,David Powers,Glen R. Rhodes,Cynthia Miller‐Stein,(unknown),(unknown),D. Berry,Todd T. Romoff,Raul R. Calvo,(unknown),(unknown),James M. Samanen	12

About Raul R. Calvo

Raul R. Calvo is a scholar working on Immunology and Allergy, Hematology and Sensory Systems, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (7 papers), Cancer-related Molecular Pathways (6 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Immunology and Allergy (241 citations), Hematology (143 citations) and Oncology (309 citations). Raul R. Calvo has collaborated with scholars based in United States and Spain. Frequent co-authors include Fadia E. Ali, Tianbao Lu, Maxwell D. Cummings, Daniel J. Parks, Karen L. Milkiewicz, Louis V. LaFrance, James M. Samanen, Jennifer Lattanze, Bruce Grasberger and Todd T. Romoff. Their work appears in journals such as Journal of the American Chemical Society, Advanced Drug Delivery Reviews and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact